During the past decade, Mayo Clinic Health Systems-Mankato conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 24 clinical trials were completed, i.e. on average, 70.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mayo Clinic Health Systems-Mankato" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "Mayo Clinic" with 10 trials sponsored, "NRG Oncology" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Health Systems-Mankato" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Health Systems-Mankato" are "Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Malignant Solid Neoplasm" (3 trials), "Prostate Cancer" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Mayo Clinic Health Systems-Mankato" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Health Systems-Mankato" are "Drug" (43 trials), "Other" (38 trials), "Radiation" (16 trials), "Biological" (15 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Quality-of-Life Assessment" (16 trials), "Paclitaxel" (10 trials), "Questionnaire Administration" (10 trials) and "Placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Health Systems-Mankato" are 43 trials for "All" genders, 12 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Mayo Clinic Health Systems-Mankato". undefined are not yet recruiting, 9 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Mayo Clinic Health Systems-Mankato, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Health Systems-Mankato, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".